FindTrial
Sign In

Evaluation of mindfulnes-based cognitive therapy (MBCT) in the treatment of depression curative effect and relapse prevention function: A randomized controlled study

Evaluation of mindfulnes-based cognitive therapy (MBCT) in the treatment of depression curative effect and relapse prevention function: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16007984
Enrollment
Unknown
Registered
2016-02-24
Start date
2016-03-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Experimental group:MBCT & antidepressant
control group:General life coaching & antidepressant

Sponsors

Beijing Hui Long Guan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Through the SCID screening, Conforms to the dsm-iv major depressive disorder diagnosis standards; (2) Aged from 18 to 60 years old, High school education level above; (3) Have capacity for civil conduct, Voluntarily participate in the study, and Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) The score of Suicide Risk Assessment>=11; (2) The treatment is not cooperation, cultural level is too low or merge serious body disease that is difficult to cooperate with treatment; (3) In patients with mental retardation; Schizophrenia, bipolar disorder and major depressive disorder in psychomotor retardation or mental illness symptoms; Use active substances caused by mental disorder.

Design outcomes

Primary

MeasureTime frame
HAMD;HAMA;FFMQ;ERP;fMRI;—

Secondary

MeasureTime frame
WHOQOL-BREF;SCSQ;—

Countries

China

Contacts

Public ContactLei Liu
liulei200608@sohu.com+86 010 62715511-6330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026